India News

Gland Pharma to invest ₹400 crore for expanding Hyderabad capacity.

Gland Pharma to invest ₹400 crore for expanding Hyderabad capacity.

Gland Pharma will be investing over ₹400 crore in adding up capabilities to their existing facility in the Genome Valley he to manufacture biologicals, biosimilar, antibodies and recombinant Insulin. The company will recrureit... Full Story

Bristol Myers Squibb to invest Rs. 800 cr for drug development in Hyderabad.

Bristol Myers Squibb, a world's leading biopharmaceutical company will establish a state of-the-art site here to expand its global drug... Full Story

Browse All News by Date

Cadila Pharmaceuticals to invest ₹100 crore to set up formulations facility in Odisha.

Ahmedabad-based Cadila Pharmaceuticals will invest ₹100 crore to set up a pharmaceuticals formulations manufacturing facility at Malipada near Bhubaneswar in... Full Story

More Top Stories

LATEST HEADLINES FROM MIDDLE EAST AND NORTH AFRICA
OUR OTHER PRODUCTS & SERVICES: Projects Database | Tenders Database | About Us | Contact Us | Terms of Use | Advertise with Us | Privacy Policy | Disclaimer | Feedback

This site is best viewed with a resolution of 1024x768 (or higher) and supports Microsoft Internet Explorer 4.0 (or higher)
Copyright © 2016-2023

Technology Partner - Pairscript Software